Abstract
New research on Artificial Intelligence is the subject of a report. According to news originating from Salzburg, Austria, by NewsRx correspondents, research stated, "Following the previous part of the narrative review on artificial intelligence (AI) applications in positron emission tomography (PET) using tracers rather than F-fluorodeoxyglucose ([F]F-FDG), in this part we review the impact of PETderived radiomics data on the diagnostic performance of other PET radiotracers, F-O-(2-fluoroethyl)-Ltyrosine ([F]F-FET), F-Fluorothymidine ([F]F-FLT) and C-Methionine ([C]C-MET). [F]F-FET-PET, using an artificial amino acid taken up into upregulated tumoral cells, showed potential in lesion detection and tumor characterization, especially with its ability to reflect glioma heterogeneity."